| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROCEPT BioRobotics Corp | Director | Common Stock | 11K | $706K | $64.04 | Jun 4, 2024 | Direct |
| PROCEPT BioRobotics Corp | Director | Stock Option (Right to Buy) | 2.53K | $11.5K | $4.56 | Jun 4, 2024 | Direct |
| VYNE Therapeutics Inc. | Director | Stock Option (right to buy) | 20K | Jan 1, 2024 | Direct | ||
| Intersect ENT, Inc. | Director | Stock Options (Right to buy) | 0 | $28.25 | May 13, 2022 | Direct | |
| Satsuma Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 0 | Jun 8, 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| PRCT | PROCEPT BioRobotics Corp | Jun 4, 2024 | 2 | $0 | 4 | Jun 6, 2024 | Director |
| VYNE | VYNE Therapeutics Inc. | Jan 1, 2024 | 1 | $0 | 4 | Jan 3, 2024 | Director |
| VYNE | VYNE Therapeutics Inc. | Dec 13, 2023 | 1 | $0 | 4 | Dec 15, 2023 | Director |
| PRCT | PROCEPT BioRobotics Corp | Jun 15, 2023 | 2 | $0 | 4 | Jun 16, 2023 | Director |
| STSA | Satsuma Pharmaceuticals, Inc. | Jun 8, 2023 | 4 | $0 | 4 | Jun 8, 2023 | Director |
| VYNE | VYNE Therapeutics Inc. | Aug 10, 2022 | 1 | $0 | 4 | Aug 12, 2022 | Director |
| PRCT | PROCEPT BioRobotics Corp | Jun 7, 2022 | 2 | $75K | 4 | Jun 9, 2022 | Director |
| STSA | Satsuma Pharmaceuticals, Inc. | Jun 3, 2022 | 1 | $0 | 4 | Jun 7, 2022 | Director |
| XENT | Intersect ENT, Inc. | May 13, 2022 | 1 | -$449K | 4 | May 16, 2022 | Director |
| PRCT | PROCEPT BioRobotics Corp | Oct 21, 2021 | 1 | $200K | 4 | Oct 25, 2021 | Director |
| VYNE | VYNE Therapeutics Inc. | Jul 19, 2021 | 1 | $0 | 4 | Jul 20, 2021 | Director |